There is a logical reason why there has been no revenue.
According to Yole Intelligence the revenue forecast for the entire Neuromorphic market was 2024 was only $28mill.
See slide 6 of BRN Investor update.
The good news is that it is all up from here.
Yole forecast the market revenue forecast to be $822mill from here by 2029 - consider the BRN Roadmap in relation to this.
PowerPoint Presentation
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.8¢ |
Change
0.003(1.16%) |
Mkt cap ! $435.4M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.8¢ | 21.5¢ | $167.7K | 780.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 1404081 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 184383 | 10 |
View Market Depth
| Last trade - 10.00am 16/06/2025 (20 minute delay) ? |
| BRN (ASX) Chart |